Form 13-F position report

HEALTHPEAK PPTYS INC COM (MD)

Reported by LDR Capital Management LLC

PEAK CUSIP 42250P103 Manager CIK 0001566089

Reported 193,268 shares, up 35,374 (22.4%) from the prior quarter.

Reported value 12.0%; share count 22.4% vs. the prior quarter.

Added
% of reported 13F value 2.42% This manager · Q2 2023
Shares 193,268 Quarter-end amount reported
Reported value $3,884,687 Fair value at quarter end
Consecutive quarters held 6 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-03-31 3941000
2022-06-30 2962000
2022-09-30 2907000
2022-12-31 3916109
2023-03-31 3468931
2023-06-30 3884687
2023-09-30 3985497
2023-12-31 4562593
2024-03-31 4949644
2024-06-30 4753549
2024-09-30 3705489
2024-12-31 2440001
2025-03-31 2511445
2025-06-30 2238969
2025-09-30 478501
2025-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarterly reported position history for HEALTHPEAK PPTYS INC COM (MD) held by LDR Capital Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 0 -24,987 (-100.0%) 0 $0 2026-01-22
Q3 2025 Reduced 24,987 -102,881 (-80.5%) 0.7% $478,501 2025-10-29
Q2 2025 Added 127,868 +3,662 (2.9%) 2.9% $2,238,969 2025-07-22
Q1 2025 Added 124,206 +3,831 (3.2%) 3.03% $2,511,445 2025-04-21
Q4 2024 Reduced 120,375 -41,649 (-25.7%) 3.31% $2,440,001 2025-02-03
Q3 2024 Reduced 162,024 -80,504 (-33.2%) 4.12% $3,705,489 2024-10-21
Q2 2024 Reduced 242,528 -21,453 (-8.1%) 4.33% $4,753,549 2024-07-26
Q1 2024 Added 263,981 +33,547 (14.6%) 3.33% $4,949,644 2024-05-01
Q4 2023 Added 230,434 +13,359 (6.2%) 2.55% $4,562,593 2024-01-24
Q3 2023 Added 217,075 +23,807 (12.3%) 2.42% $3,985,497 2023-10-30
Q2 2023 Added 193,268 +35,374 (22.4%) 2.42% $3,884,687 2023-08-07
Q1 2023 Added 157,894 +1,687 (1.1%) 2.28% $3,468,931 2023-05-10
Q4 2022 Added 156,207 +29,361 (23.1%) 2.15% $3,916,109 2023-02-07
Q3 2022 Added 126,846 +12,523 (11.0%) 1.47% $2,907,000 2022-11-09
Q2 2022 Reduced 114,323 -477 (-0.4%) 1.24% $2,962,000 2022-08-12
Q1 2022 New 114,800 +114,800 (0.0%) 1.24% $3,941,000 2022-05-11

Who else reported the position

662 managers reported HEALTHPEAK PPTYS INC COM (MD) for Q2 2023.

Managers reporting HEALTHPEAK PPTYS INC COM (MD) in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 88,088,596 -1,137,181 0.04% $1,770,580,780 15 qtrs
BlackRock Inc Reduced 54,985,612 -2,385,215 0.03% $1,105,210,791 15 qtrs
STATE STREET CORPORATION Added 39,522,044 +290,998 0.04% $794,393,084 15 qtrs
Invesco Ltd Added 22,919,055 +906,533 0.12% $460,673,010 15 qtrs
JPMorgan Chase & Co Added 15,610,332 +6,698,030 0.03% $313,767,674 15 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 12,702,280 +155,952 0.03% $254,702,418 15 qtrs
Resolution Capital Ltd Reduced 10,675,649 -1,527,846 3.54% $214,580,545 15 qtrs
CENTERSQUARE INVESTMENT MANAGEMENT LLC Added 9,149,325 +2,539,759 2.16% $183,901,433 15 qtrs
Legal & General Group Plc Added 8,951,847 +328,037 0.06% $179,932,021 15 qtrs
AMERICAN CENTURY COMPANIES INC Reduced 8,813,066 -60,587 0.13% $177,142,619 15 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 07, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
193,268
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.